Penumbra PEN
NYSE PEN
$324.93 -1.90 (-0.58%)
At close: Aug 20, 2026 · 1:21 PM UTC

Penumbra (PEN) Selling, General & Administrative (2014 - 2026)

Penumbra (PEN) Selling, General & Administrative (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Abbott Laboratories 198.95 Bn 193.35 Bn 7.27 Bn 4.03 Bn
2 Stryker 128.10 Bn 124.63 Bn 4.50 Bn 2.23 Bn
3 Medtronic 118.91 Bn 109.69 Bn 6.41 Bn 3.06 Bn
4 Boston Scientific 73.43 Bn 72.89 Bn 3.85 Bn 1.80 Bn
5 Edwards Lifesciences 51.91 Bn 47.66 Bn 1.35 Bn 561.20 Mn
6 Dexcom 34.52 Bn 32.58 Bn 830.00 Mn 358.70 Mn
7 GE HealthCare Technologies 33.94 Bn 31.83 Bn 2.18 Bn 1.12 Bn
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn -179.00 Mn
9 Steris 23.14 Bn 22.66 Bn 684.20 Mn 369.70 Mn
10 Penumbra 12.79 Bn 12.13 Bn 264.94 Mn 198.51 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 198.51 Mn
Mar 31, 2026 192.80 Mn
Dec 31, 2025 181.10 Mn
Sep 30, 2025 168.90 Mn
Jun 30, 2025 159.96 Mn
Mar 31, 2025 153.46 Mn
Dec 31, 2024 147.94 Mn
Sep 30, 2024 139.74 Mn
Jun 30, 2024 141.90 Mn
Mar 31, 2024 144.41 Mn
Dec 31, 2023 130.02 Mn
Sep 30, 2023 125.92 Mn
Jun 30, 2023 127.44 Mn
Mar 31, 2023 123.08 Mn
Dec 31, 2022 115.63 Mn
Sep 30, 2022 108.57 Mn
Jun 30, 2022 114.62 Mn
Mar 31, 2022 110.90 Mn
Dec 31, 2021 113.50 Mn
Sep 30, 2021 94.40 Mn